An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

No gold standard has been established as a primary endpoint in trials of initial treatment of chronic graft-versus-host disease (GVHD), and evidence showing the association of any proposed primary endpoint with clinical benefit has not been conclusively demonstrated. To address this gap, we analyzed...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood
Hoofdauteurs: Martin, Paul J., Storer, Barry E., Inamoto, Yoshihiro, Flowers, Mary E. D., Carpenter, Paul A., Pidala, Joseph, Palmer, Jeanne, Arora, Mukta, Jagasia, Madan, Arai, Sally, Cutler, Corey S., Lee, Stephanie J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2017
Onderwerpen:
Transplantation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520473/
https://ncbi.nlm.nih.gov/pubmed/28495794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-03-775767
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items